Literature DB >> 6419128

A lymphocyte-specific enhancer in the mouse immunoglobulin kappa gene.

D Picard, W Schaffner.   

Abstract

During differentiation of lymphocytes into antibody-producing cells, an immunoglobulin kappa variable-region gene is transcriptionally activated by rearrangement linking it to a kappa constant (C kappa) region gene which is already transcribed prior to somatic rearrangement. The presence of a transcriptional enhancer element within the large intron of the kappa light-chain gene has been postulated to explain this mode of activation, supported by evidence of a chromatin region which is preferentially accessible to DNase I and restriction enzymes. This DNA region contains a segment of about 130 base pairs (bp) which is strongly conserved between mouse, rabbit and man. Moreover, no transcripts are detectable from a kappa gene, which is truncated within the large intron. Recently, a lymphocyte-specific enhancer has been identified downstream of the joining region in immunoglobulin heavy-chain genes. We now show direct evidence for a functionally similar enhancer within the large kappa gene intron of the mouse. It is, however, less active than the heavy-chain gene enhancer. In contrast, no enhancer was found to be associated with a cloned lambda I light-chain gene.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6419128     DOI: 10.1038/307080a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  151 in total

1.  Genome-wide analysis of clustered Dorsal binding sites identifies putative target genes in the Drosophila embryo.

Authors:  Michele Markstein; Peter Markstein; Vicky Markstein; Michael S Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

2.  Different E-box regulatory sequences are functionally distinct when placed within the context of the troponin I enhancer.

Authors:  K E Yutzey; S F Konieczny
Journal:  Nucleic Acids Res       Date:  1992-10-11       Impact factor: 16.971

3.  Characterization of a new tissue-specific transcription factor binding to the simian virus 40 enhancer TC-II (NF-kappa B) element.

Authors:  A L Lattion; E Espel; P Reichenbach; C Fromental; P Bucher; A Israël; P Baeuerle; N R Rice; M Nabholz
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

4.  Expression of heat shock-regulated human growth hormone genes containing or lacking introns by NIH-3T3 and Wish cell lines.

Authors:  S Alouani; P L'Hote; J B Marq; L M Houdebine; F Montandon; M Chessebeuf-Padieu; M Dreano
Journal:  Cell Biol Toxicol       Date:  1992 Apr-Jun       Impact factor: 6.691

5.  Interaction of a nuclear protein with a palindromic sequence of the mouse immunoglobulin lambda 2-chain gene promoter is important for its transcription.

Authors:  L A Chang; H Murialdo
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

6.  The importance of the 3'-enhancer region in immunoglobulin kappa gene expression.

Authors:  K B Meyer; M J Sharpe; M A Surani; M S Neuberger
Journal:  Nucleic Acids Res       Date:  1990-10-11       Impact factor: 16.971

7.  Genomic characterization of a gamma-interferon-inducible gene (IP-10) and identification of an interferon-inducible hypersensitive site.

Authors:  A D Luster; J V Ravetch
Journal:  Mol Cell Biol       Date:  1987-10       Impact factor: 4.272

8.  Elucidation of IgH intronic enhancer functions via germ-line deletion.

Authors:  Thomas Perlot; Frederick W Alt; Craig H Bassing; Heikyung Suh; Eric Pinaud
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-26       Impact factor: 11.205

9.  A gamma interferon-unresponsive variant of cell line 70Z/3, IFN-4, can be partially rescued by phorbol myristate acetate.

Authors:  D W Emery; J W Rooney; C H Sibley
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

10.  Enhancer-dependent expression of human kappa immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation.

Authors:  H Potter; L Weir; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.